Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Athersys Inc (NASDAQ:ATHX)

2.15
Delayed Data
As of Jul 25
 0.00 / 0.00%
Today’s Change
0.94
Today|||52-Week Range
2.90
+108.74%
Year-to-Date
No recent news for Athersys Inc.

Today’s Trading

Previous close2.15
Today’s open2.13
Day’s range2.11 - 2.21
Volume194,846
Average volume (3 months)681,988
Market cap$181.4M
Dividend yield--
Data as of 3:59pm ET, 07/25/2016

Growth & Valuation

Earnings growth (last year)+35.48%
Earnings growth (this year)-16.67%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+636.17%
P/E ratio107.5
Price/Sales7.14
Price/Book9.13

Competitors

 Today’s
change
Today’s
% change
RGLSRegulus Therapeutics...+0.03+0.87%
GLYCGlycoMimetics Inc+0.48+5.91%
NYMXNymox Pharmaceutical...+0.05+1.26%
ARGSArgos Therapeutics I...-0.40-5.87%
Data as of 4:00pm ET, 07/25/2016

Financials

Next reporting dateAugust 8, 2016
EPS forecast (this quarter)-$0.10
Annual revenue (last year)$11.9M
Annual profit (last year)-$16.4M
Net profit margin-137.45%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Gil van Bokkelen
President, Chief Operating Officer &
Secretary
William B. J. Lehmann
Corporate headquarters
Cleveland, Ohio

Forecasts

Partner Offers

Search for Jobs